Amedisys Stock In The News

AMED Stock  USD 93.61  0.08  0.09%   
The tone or emotional content of news articles related to Amedisys can affect its stock prices. Positive news sentiment can lead to an increase in demand for Amedisys' stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of Amedisys' news coverage and content from conventional and social sources shows investors' bearish mood towards Amedisys. The specific impact of Amedisys news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Amedisys' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Amedisys headlines in addition to utilizing other, more conventional financial analysis modules. Check out Amedisys Backtesting and Amedisys Hype Analysis.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.

Amedisys Today Top News and Investor Outlook

Yahoo News
Amedisys Inc (AMED) Reports Mixed Results Amidst Merger Transactions
https://finance.yahoo.com/news/amedisys-inc-amed-reports-mixed-215700349.html
 Bullish
Yahoo News
Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results
https://finance.yahoo.com/news/amedisys-reports-fourth-quarter-end-213000259.html
 Bullish
Yahoo News
Amedisys (AMED) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
https://finance.yahoo.com/news/amedisys-amed-expected-beat-earnings-150051705.html
 Bullish
Yahoo News
Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis
https://finance.yahoo.com/news/amedisys-offers-molecular-testing-rapid-123000433.html
 Bullish
Yahoo News
3 Stocks To Turn $1,000 Into $10,000 in 10 Years
https://finance.yahoo.com/news/3-stocks-turn-1-000-200035720.html
 Bullish
Yahoo News
20 Most Medically Advanced Countries in the World Heading into 2024
https://finance.yahoo.com/news/20-most-medically-advanced-countries-013156904.html
 Bullish
Yahoo News
Chemed (CHE) Up 4.8% Since Last Earnings Report: Can It Continue?
https://finance.yahoo.com/news/chemed-che-4-8-since-163125442.html
 Bullish
Yahoo News
Amedisys (AMED) Up 2.6% Since Last Earnings Report: Can It Continue?
https://finance.yahoo.com/news/amedisys-amed-2-6-since-163045966.html
 Bullish
Yahoo News
3 Stocks Profiting from America’s Long-Term Care Crisis
https://finance.yahoo.com/news/3-stocks-profiting-america-long-184455216.html
 Bullish
Yahoo News
Amedisys' (AMED) Q3 Earnings Miss Estimates, Margins Up
https://finance.yahoo.com/news/amedisys-amed-q3-earnings-miss-121900011.html
 Bullish

Amedisys Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Amedisys and other traded companies coverage. We help investors stay connected with Amedisys headlines for the 22nd of February to make an informed investment decision based on correlating the impacts of news items on Amedisys Stock performance. Please note that trading solely based on the Amedisys hype is not for everyone as timely availability and quick action are needed to avoid losses.
Amedisys' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Amedisys investors visualize upcoming and past events in order to time the market based on Amedisys noise-free hype analysis.
Amedisys stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Amedisys earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Amedisys that are available to investors today. That information is available publicly through Amedisys media outlets and privately through word of mouth or via Amedisys internal channels. However, regardless of the origin, that massive amount of Amedisys data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Amedisys news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Amedisys relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Amedisys' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Amedisys alpha.

Amedisys Largest EPS Surprises

Earnings surprises can significantly impact Amedisys' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2003-05-13
2003-03-310.080.090.0112 
2002-11-11
2002-09-300.080.10.0225 
2014-05-08
2014-03-31-0.04-0.07-0.0375 
2012-08-07
2012-06-300.240.270.0312 
2003-08-12
2003-06-300.090.120.0333 
2002-08-07
2002-06-300.160.13-0.0318 
View All Earnings Estimates

Amedisys Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Amedisys Stock. Current markets are slightly bearish. About 58% of major world exchanges and indexes are down. See today's market update for more information.
Yahoo News
21st of February 2024
Amedisys Q4 Earnings Lag Estimates
at finance.yahoo.com 
zacks News
14th of February 2024
Amedisys Expected to Beat Earnings Estimates What to Know Ahead of Q4 Release
at zacks.com 
Google News at Macroaxis
12th of February 2024
Amedisys Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
at news.google.com 
Yahoo News
8th of February 2024
Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis
at finance.yahoo.com 
Yahoo News
6th of February 2024
Home Healthcare Market Worth 383.0 Billion MarketsandMarkets.
at finance.yahoo.com 
news
31st of January 2024
Amedisys Research Coverage Started at StockNews.com
at thelincolnianonline.com 
news
22nd of January 2024
Amedisys Research Coverage Started at StockNews.com
at thelincolnianonline.com 
Google News at Macroaxis
11th of January 2024
Amedisys, Inc. Shares Acquired by ING Groep NV - MarketBeat
at news.google.com 
news
3rd of January 2024
Amedisys, Inc. Short Interest Up 9.1 percent in December
at thelincolnianonline.com 
benzinga news
29th of December 2023
Richard Ashworth Exercises Options, Realizes 171K
at benzinga.com 
news
4th of December 2023
Credit Suisse AG Has 31.71 Million Holdings in Amedisys, Inc.
at thelincolnianonline.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amedisys in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amedisys' short interest history, or implied volatility extrapolated from Amedisys options trading.
When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:
Check out Amedisys Backtesting and Amedisys Hype Analysis.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
Note that the Amedisys information on this page should be used as a complementary analysis to other Amedisys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Amedisys Stock analysis

When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Is Amedisys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.001
Earnings Share
0.08
Revenue Per Share
68.4
Quarterly Revenue Growth
(0)
Return On Assets
0.0604
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.